95.11MMarket Cap0.10P/E (TTM)
9.3848High8.1900Low94.82KVolume8.5500Open8.8100Pre Close821.33KTurnover3.28%Turnover RatioLossP/E (Static)10.46MShares34.460052wk High4.51P/B26.31MFloat Cap3.950152wk Low--Dividend TTM2.89MShs Float22031.7120Historical High--Div YieldTTM13.56%Amplitude3.9501Historical Low8.6610Avg Price1Lot Size
Avalo Therapeutics Stock Forum
Avalo Therapeutics Receives $69.4 Million in Proceeds From the Full Exercise of Private Placement Warrants
Avalo Announces First Patient Dosed in Phase 2 LOTUS Trial of AVTX-009 for the Treatment of Hidradenitis Suppurativa
• Global study in approximately 180 adults with hidradenitis suppurativa to assess the efficacy and safety of two dose regimens of AVTX-009 compared to placebo
• Topline data expected in 2026
Chi chif lao wai cheo? = They block Short why trade 😭😭😭😭😭
No comment yet